Transdermal nitroglycerin for preterm labor

References

• Di Renzo GC, Roura LC; European Association of Perinatal Medicine Study Group on Preterm Birth. Guidelines for the management of spontaneous preterm labor. J. Perinat. Med.34(5), 359–366 (2006).
   PubMed Web of Science ®Google Scholar
• Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J; PERISTAT Study Group. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. Br. J. Obstet. Gynaecol.113(5), 528–535 (2006).
   Google Scholar
• The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the β-adrenergic agonist ritodrine. N. Engl. J. Med.327(5), 308–312 (1992).
   PubMed Web of Science ®Google Scholar
• Leveno KJ, Cunningham FG. β-adrenergic agonists for preterm labor. N. Engl. J. Med.327(5), 349–351 (1992).
   PubMed Web of Science ®Google Scholar
• Lamont RF. The pathophysiology of pulmonary oedema with the use of β-agonists. Br. J. Obstet. Gynaecol.107(4), 439–444 (2000).
   Google Scholar
• Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst. Rev. (2), CD000940 (2001).
   Google Scholar
• Royal College of Obstetricians and Gynecologists. Clinical Green Top Guidelines. Tocolytic Drugs for Women in Preterm Labour (1B). RCOG, London, UK (2002).
   Google Scholar
• Moutquin JM, Sherman D, Cohen H et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am. J. Obstet. Gynecol.182(5), 1191–1199 (2000).
   PubMed Web of Science ®Google Scholar
• Schmitz T, Cabrol D. Tocolysis. Atosiban, an ocytcin-receptor antagonist. J. Gynecol. Obstet. Biol. Reprod. (Paris)30(3), 238–245 (2001).
   PubMedGoogle Scholar
• Lamont RF, Khan KS, Beattie B et al; Steering Group of the International Preterm Labour Council. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J. Perinat. Med.33(4), 287–295 (2005).
   PubMed Web of Science ®Google Scholar
• Van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. Br. J. Obstet. Gynaecol.112(Suppl. 1), 79–83 (2005).
   Google Scholar
• Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet343(8909), 1325–1326 (1994).
   PubMed Web of Science ®Google Scholar
• Lees CC, Lojacono A, Thompson C et al. Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet. Gynecol.94(3), 403–408 (1999).
   PubMed Web of Science ®Google Scholar
• Smith GN, Walker MC, McGrath MJ. Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br. J. Obstet. Gynaecol.106(7), 736–739 (1999).
   PubMedGoogle Scholar
• Jennings RW, MacGillivray TE, Harrison MR. Nitric oxide inhibits preterm labour in Rhesus monkeys. J. Maternal Fetal Med.2, 170–175 (1993).
   Google Scholar
• Smith GN, Brien JF. Use of nitroglycerin for uterine relaxation. Obstet. Gynecol. Surv.53(9), 559–565 (1998).
   PubMedGoogle Scholar
• Smith GN, Walker MC, Ohlsson A, O’Brien K, Windrim R; Canadian Preterm Labour Nitroglycerin Trial Group. Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor. Am. J. Obstet. Gynecol.196(1), 37.e1–37.e8 (2007).
   Google Scholar
• Neri I, Di Renzo GC, Caserta G, Gallinelli A, Facchinetti F. Impact of the l-arginine/nitric oxide system in pregnancy. Obstet. Gynecol. Surv.50, 851–858 (1995).
   PubMedGoogle Scholar
• De Pace V, Chiossi G, Facchinetti F. Clinical use of nitric oxide donors and l-arginine in obstetrics. J. Mat. Fet. Neonat. Med. (2007) (In press).
   PubMedGoogle Scholar
• Pagliaro P. Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. Life Sci.73, 2137–2149 (2003).
   PubMed Web of Science ®Google Scholar
• Rowlands S, Trudinger B, Visva-Lingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate, a nitric oxide donor. Aust. NZ J. Obstet. Gynaecol.36, 377–381 (1996).
   PubMed Web of Science ®Google Scholar
• Haghighi L, Akbarian A. Isosorbide dinitrate for treatment of preterm labor. Int. J. Gynaecol. Obstet.89, 274–275 (2005).
   PubMed Web of Science ®Google Scholar
• Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labor. Cochrane Database Syst. Rev. (3), CD002860 (2002).
   Google Scholar
• Buhimschi CS, Buhimschi IA, Malinow AM, Weiner CP. Effects of sublingual nitroglycerin on human uterine contractility during the active phase of labor. Am. J. Obstet. Gynecol.187, 235–238 (2002).
   PubMed Web of Science ®Google Scholar
• Berghella V, Ness A, Bega G, Berghella A. Cervical sonography in women with symptoms of preterm labour. Obstet. Gynecol. Clin. North Am.32, 383–396 (2005).
   PubMedGoogle Scholar
• Honest H, Bachmann LM, Sundaram R, Gupta JK, Kleijnen J, Khan KS. The accuracy of risk scores in predicting preterm birth – a systematic review. Br. J. Obstet. Gynaecol.24(4), 343–359 (2004).
   Google Scholar
• Meis PJ, Klebanoff M, Thom E et al; National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 α-hydroxyprogesterone caproate. N. Engl. J. Med.348(24), 2379–2385 (2003). Erratum in: N. Engl. J. Med.349(13), 1299 (2003).
   PubMed Web of Science ®Google Scholar
• Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol.188, 419–424 (2003).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17α-hydroxy-progesterone caproate. Am. J. Obstet. Gynecol.196(5), 453.e1–453.e4 (2007).
   PubMed Web of Science ®Google Scholar
• James MA, Papouchado M, Jones JV. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance. Eur. Heart J.12(12), 1266–1272 (1991).
   PubMedGoogle Scholar
• Kim D, Rybalkin SD, Pi X et al. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation104(19), 2338–2343 (2001).
   PubMed Web of Science ®Google Scholar